Safety and tolerability of ibrutinib monotherapy in Japanese patients with relapsed/refractory B cell malignancies

Kensei Tobinai, Michinori Ogura, Kenichi Ishizawa, Tatsuya Suzuki, Wataru Munakata, Toshiki Uchida, Tomohiro Aoki, Takanobu Morishita, Yoko Ushijima, Satoko Takahara

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and tolerability of ibrutinib monotherapy in Japanese patients with relapsed/refractory B cell malignancies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases